Why Beacon?
Become a Beacon CVRM founding partner to secure exclusive early access to our Obesity drug development data.
Discover how Beacon CVRM enables data-drive insight that will accelerate your Obesity drug development decisions.
- Validate Obesity asset potential with insights on competitor programs, clinical outcomes, and market activity
- Explore Obesity drug design strategies from delivery system and target organ/cell to emerging target investigations
- Benchmark your research with validated preclinical data (blood-brain barrier penetration data included), including publication summaries, and links to conference abstracts and posters
- Optimize clinical trial design by analyzing trial endpoints, outcomes, and regulatory precedents, to accelerate progression into the clinic
Join 24/25 top Pharma companies who use Beacon to accelerate and improve their drug development decisions.
Request Beacon CVRM Obesity Data Early Access
Please submit the form below to request early access to Beacon CVRMs Obesity drug development data. A member of our specialized team will be in touch shortly to schedule a time that suits you.
How is Beacon CVRM Different?
- A Unique CVRM Dataset: Comprehensive & accurate, preclinical and clinical, CVRM drug and trial to inform your CVRM drug development decisions
- In Depth Preclinical Data: Including preclinical publication summaries, and links to conference abstracts and posters
- Proprietary Ontologies: Market leading standardized ontologies, enabling you to easily segment the CVRM drug development landscape, to quickly find the data that matters to you
- Human Intelligence: Beacon CVRM data is manually curated by sector specialist analysts, to ensure data accuracy and integrity
Search